Advanced Filters
noise

Viladecans, Spain Clinical Trials

A listing of Viladecans, Spain clinical trials actively recruiting patients volunteers.

Found 704 clinical trials
I Isabel Blanco, MD, PhD

Urban-training Intervention in Pulmonary Hypertension (UTHAP)

Pulmonary rehabilitation is effective in the treatment of pulmonary hypertension (PH). However, the beneficial effects of such intervention have been seen to disappear over time in other chronic diseases. The objective of the project is to evaluate the efficacy of an urban exercise program after a rehabilitation program and to …

18 - 99 years of age All Phase N/A

Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.

A Randomized, Double-Blinded, Placebo-Controlled, Prospective, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Immunotherapy in Patients With Rhinitis With or Without Mild to Moderate Asthma Sensitized to cupressaceae and grasses.

12 - 65 years of age All Phase 3

A Scalable Psychological Intervention to Reduce Psychological Distress Among Workers of Assisted Living Facilities

The current study is a randomized controlled trial (RCT) that aims to evaluate the effectiveness of a stepped-care program (Doing What Matters [DWM] and Problem Management Plus [PM+]) in reducing anxiety and depression symptoms amongst long-term care workers (LTCWs), following changes in care due to the COVID-19 pandemic.

18 - 65 years of age All Phase N/A
P Pablo Moreno

Usefulness of ICG Angiography-Guided Thyroidectomy for Preserving Parathyroid Function

Transient and/or permanent hypoparathyroidism is the most frequent complication after total thyroidectomy. The identification of the parathyroid glands and a correct dissection during thyroidectomy have been postulated as key factors for their preservation and, consequently, to prevent hypoparathyroidism. The use of indocyanine green (ICG) fluorescence has reliably predicted parathyroid glands …

18 - 100 years of age All Phase N/A

Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease

Multicenter, prospective, non-controlled study in a pediatric cohort (<6 years-old) with severe (type 2 or 3) hereditary Von Willebrand Disease (VWD).

2 - 6 years of age All Phase 4
a ana cruceta

Efficacy of Simvastatin in Alcoholic Liver Fibrosis

Evaluate the efficacy of simvastatin in reducing liver fibrosis in patients with advanced fibrosis due to alcohol

18 years of age All Phase 2/3

Safety And Performance Of Disc Care To Prevent Lumbar Disc Herniation Recurrence

The goal of this clinical investigation is to learn about DISC Care, an Hernia Blocking System, in patients who have undergone lumbar disc hernia surgery. The main questions it aims to answer are: if the implant (DISC Care) prevents disc herniation recurrence if DISC Care is a safe device Participants …

18 - 75 years of age All Phase N/A
R Ricardo Frago, Ph D

Sarcopenia in Colorectal Cancer Patients, Intervention Study

The sarcopenia is a new concept for evaluating the functional status of patients, introduced during the last 20 years. This is defined as the relationship between the deterioration of muscle mass and the decrease in strength, the metabolic rate, the aerobic capacity and subsequently the evaluation of the functional status. …

70 years of age All Phase N/A
B Berangere Midez

First in Human Study of T3P-Y058-739 (T3P)

This is a first in human, phase I/II open-label, dose-finding, safety, and proof-of-concept clinical trial of T3P-Y058-739, a genetically-modified, live attenuated strain of the bacterium Yersinia enterocolitica, in patients with advanced solid tumors.

18 - 74 years of age All Phase 1/2
N Nikolaos P Polyzos, MD PhD

INtensity of OVarian Stimualtion and Euploid Embryos

This randomized trial was designed as a no-inferiority trial aiming to evaluate if the intensity of stimulation (a milder vs a more intense approach) may have an impact on the number of euploid embryos and the morpho kinetic parameters in advanced age women undergoing PGT-A with a PPOS protocol.

38 - 42 years of age Female Phase 4

Simplify language using AI